Correlation Between Neuropace and Edwards Lifesciences

Can any of the company-specific risk be diversified away by investing in both Neuropace and Edwards Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Edwards Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neuropace and Edwards Lifesciences Corp, you can compare the effects of market volatilities on Neuropace and Edwards Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Edwards Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Edwards Lifesciences.

Diversification Opportunities for Neuropace and Edwards Lifesciences

0.63

Correlation Coefficient

Neuropace  Edwards Lifesciences

Poor diversification

The 3 months correlation between Neuropace and Edwards is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Edwards Lifesciences Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Edwards Lifesciences Corp and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Edwards Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Edwards Lifesciences Corp has no effect on the direction of Neuropace i.e., Neuropace and Edwards Lifesciences go up and down completely randomly.

Pair Corralation between Neuropace and Edwards Lifesciences

Given the investment horizon of 90 days Neuropace is expected to generate 2.01 times more return on investment than Edwards Lifesciences. However, Neuropace is 2.01 times more volatile than Edwards Lifesciences Corp. It trades about 0.04 of its potential returns per unit of risk. Edwards Lifesciences Corp is currently generating about 0.01 per unit of risk. If you would invest  928.00  in Neuropace on September 13, 2024 and sell it today you would earn a total of  180.00  from holding Neuropace or generate 19.4% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Neuropace  vs.  Edwards Lifesciences Corp

Neuropace

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Edwards Lifesciences Corp

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Edwards Lifesciences Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting basic indicators, Edwards Lifesciences may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Neuropace and Edwards Lifesciences

The main advantage of trading using opposite Neuropace and Edwards Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Edwards Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edwards Lifesciences will offset losses from the drop in Edwards Lifesciences' long position.

The idea behind Neuropace and Edwards Lifesciences Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.